GWP
IDXX icon

Gateway Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Gateway Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
380
-121
-24% -$67.9K 0.01% 741
2026
Q1 		$282K Buy
+501
New +$321K 0.01% 784

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Gateway Wealth Partners's IDXX Position: Q2 2026 in Review

Gateway Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 24% in Q2 2026, selling an estimated $67.9K and leaving 380 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #741.

Gateway Wealth Partners first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $282K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Gateway Wealth Partners held 380 shares of Idexx Laboratories worth $200K as of Q2 2026.
  • Gateway Wealth Partners sold 121 Idexx Laboratories shares in Q2 2026, an estimated $67.9K.
  • Idexx Laboratories made up 0.01% of Gateway Wealth Partners's portfolio in Q2 2026, its #741 holding.
  • Gateway Wealth Partners first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Gateway Wealth Partners's Idexx Laboratories position peaked at $282K in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.